MycoMed Technologies focuses on development and commercialization of products to enable early detection and prevention of fungal infections.
MycoMed Technologies is focused on the development and commercialization of products to enable early detection and prevention of fungal infections in patients who receive organ transplants, cancer therapy, or immunosuppressant medications.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 26, 2015 | Grant | $174.99K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |